TRXB
TRex Bio, Inc. - Common stock (TRXB)
$81
About TRex Bio, Inc. - Common stock (TRXB)
Trex Bio, Inc. engages in the manufacture of immunotherapies for autoimmune and inflammatory diseases. It focuses on studying the regulation of tissue inflammation to develop breakthrough medicines. The company was founded by Houman Ashrafian, Adil Daud, Wilson Liao, Diane Mathis, Drew Pardoll, Michael Rosenblum, Alison Simmons, and Jim Wells in May 24, 2018 and is headquartered in South San Francisco, CA.
Details
Daily high
$14.08
Daily low
$13.72
Price at open
$13.95
52 Week High
$15.50
52 Week Low
$13.50
Market cap
385.1M
Dividend yield
-
Volume
40,127
Avg. volume
482,514
P/E ratio
--
TRex Bio, Inc. - Common stock News
Details
Daily high
$14.08
Daily low
$13.72
Price at open
$13.95
52 Week High
$15.50
52 Week Low
$13.50
Market cap
385.1M
Dividend yield
-
Volume
40,127
Avg. volume
482,514
P/E ratio
--